Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (TCTR20251007003) titled 'Comparison of the Efficacy of Noninvasive Treatments in Muscle Painful Temporomandibular Joint Disorders' on Oct. 7.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Akdeniz University, Faculty of Dentistry
Condition:
Temporomandibular muscle disorders
Disorders, Temporomandibular Joint
Disorders, Temporomandibular Joint
Intervention:
Participants receive Magnorm 365 mg (effervescent tablet) once daily for 4 weeks. Rescue medication permitted as paracetamol 500 mg up to three times daily if needed. No other TMD-directed therapy is allowed during the trial period.,Photobiomodulation to t...